Literature DB >> 4389660

Antipseudomonal activity of alpha-sulfoaminopenicillins.

K E Price, D R Chisholm, F Leitner, M Misiek, A Gourevitch.   

Abstract

A series of penicillins characterized by the presence of a sulfoamino or a modified sulfoamino group in the side chain was subjected to in vitro antimicrobial screening tests. Although the most potent members of the series were less active than benzylpenicillin against gram-positive bacteria and comparably active against most gram-negative bacteria, they were, on the average, 8 to 16 times more effective against strains of Pseudomonas aeruginosa. In other comparative laboratory tests against P. aeruginosa, these compounds were about as active as carbenicillin and four to eight times more active than ampicillin. An examination of structure-activity relationships indicated that maximal potency was obtained with penicillins having an alpha-(aromatic or heteroaromatic)-alpha-sulfoaminoacetamido side chain. The compound with an alpha-phenyl group was comparable in activity to those having an alpha-(2- or 3-thienyl) group, whereas any modification in position or structure of the alpha-sulfoamino group reduced activity. Results of studies with a cell-free P. aeruginosa beta-lactamase suggest that the marked inhibitory effects of alpha-sulfoamino penicillins for P. aeruginosa can be attributed, at least in part, to their high degree of resistance to this enzyme. Some derivatives, however, had weak antipseudomonal activity, despite possessing a high degree of beta-lactamase resistance.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4389660      PMCID: PMC377831          DOI: 10.1128/am.17.6.881-887.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  11 in total

1.  Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea.

Authors:  W Brumfitt; A Percival; D A Leigh
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

2.  Local chemoprophylaxis for burns with gentamicin and other agents.

Authors:  E J Lowbury; D M Jackson
Journal:  Lancet       Date:  1968-03-30       Impact factor: 79.321

3.  Oral administration of sodium colistin methanesulfonate on urinary tract infections.

Authors:  T Nishimura; Y Kawada; M Tahara; H Mizutani; R Miyamura
Journal:  J Antibiot (Tokyo)       Date:  1967-11       Impact factor: 2.649

4.  In vitro activity of carbenicillin against gram-negative bacilli.

Authors:  G P Bodey; L M Terrell
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

5.  Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin.

Authors:  R J Jones; E J Lowbury
Journal:  Br Med J       Date:  1967-07-08

6.  Bacteriological observations on carbenicillin in the control of Pseudomonas aeruginosa infection in burns.

Authors:  C E Van Rooyen; J F Ross; G W Bethune; A C MacDonald
Journal:  Can Med Assoc J       Date:  1967-11-11       Impact factor: 8.262

7.  Intravenous administration of sodium colistimethate in urinary tract infections.

Authors:  S Olesen; P O Madsen
Journal:  Curr Ther Res Clin Exp       Date:  1967-06

8.  Dosage of gentamicin for pseudomonas infections.

Authors:  J H Darrell; P M Waterworth
Journal:  Br Med J       Date:  1967-05-27

9.  New semi-synthetic penicillin active against Pseudomonas pyocyanea.

Authors:  P Acred; D M Brown; E T Knudsen; G N Rolinson; R Sutherland
Journal:  Nature       Date:  1967-07-01       Impact factor: 49.962

10.  Carbenicillin: activity in vitro and absorption and excretion in normal young men.

Authors:  C B Smith; M Finland
Journal:  Appl Microbiol       Date:  1968-11
View more
  5 in total

1.  Comparative in vitro evaluation of BL-P1654 and carbenicillin against Pseudomonas.

Authors:  G D Overturf; R Ressler; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

2.  Intra-skeletal vascular density in a bipedal hopping macropod with implications for analyses of rib histology.

Authors:  Tahlia J Stewart; Julien Louys; Justyna J Miszkiewicz
Journal:  Anat Sci Int       Date:  2021-01-22       Impact factor: 1.741

3.  Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro.

Authors:  H C Neu; E B Winshell
Journal:  Appl Microbiol       Date:  1971-01

4.  PC-904, a novel broad-spectrum semisynthetic penicillin with marked antipseudomonal activity: microbiological evaluation.

Authors:  H Noguchi; Y Eda; H Tobiki; T Nakagome; T Komatsu
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

5.  In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin.

Authors:  G P Bodey; B Deerhake
Journal:  Appl Microbiol       Date:  1971-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.